Search Results
Nov 10, 2025, 07:33 ET RSPO Serukan Peningkatan Inklusi Petani Kecil dan Adopsi Teknologi yang Lebih Luas
Malaysia, menyoroti peran solusi ilmiah dalam mendorong sektor kelapa sawit berkelanjutan. "Sains telah menghadirkan berbagai terobosan dari pengujian DNA untuk kualitas benih hingga pemanfaatan biomassa dalam ekonomi sirkular. Tantangan terbesar kita bukan lagi inovasi, tetapi implementasi". Sebagai seorang
More news about: Roundtable On Sustainable Palm Oil
Nov 10, 2025, 07:30 ET Fapon to Showcase Innovative Molecular Diagnostic Solutions at AMP 2025 Annual Meeting & Expo
ProPrime Taq DNA Polymerase delivers ultra-fast amplification, exceptional resistance to inhibitors and superior sensitivity. PreciAmp Bst DNA Polymerase enables fast LAMP amplification with high speed,
More news about: Fapon
Nov 10, 2025, 07:00 ET Hamilton Lane Strengthens North America Client Solutions Team, Appointing Seven Senior Members
needs of clients of any size – from individuals to institutions – and doing so with the high-quality service that has always been at the core of our DNA." Today, Hamilton Lane serves more than 2,330 clients globally*, ranging from large institutions to family offices to private wealth
More news about: Hamilton Lane
Nov 10, 2025, 03:48 ET Trillion-Dollar Digital Healthcare Transformations Shaped by AI, Quantum and Biotech Breakthroughs at GITEX GLOBAL
revealed, "We have programs across liver, muscle, the brain, where we're actively working on curing genetic diseases using this method of changing the DNA. We've started with rare diseases, but there's no reason that we have to stop there. Imagine how many millions of lives this could save."
More news about: GITEX
Nov 10, 2025, 03:39 ET Trillion-Dollar Digital Healthcare Transformations Shaped by AI, Quantum and Biotech Breakthroughs at GITEX GLOBAL
revealed, "We have programs across liver, muscle, the brain, where we're actively working on curing genetic diseases using this method of changing the DNA. We've started with rare diseases, but there's no reason that we have to stop there. Imagine how many millions of lives this could save."
More news about: GITEX
Nov 10, 2025, 03:00 ET Primrose Bio Launches Prima RNApols™ ExTend Cap AU, a Next-Gen RNA Polymerase for Self-Amplifying mRNA
ExTend Cap AU enables high-yield, fully capped self-amplifying mRNA with less capping reagent, template DNA and RNA polymerase. Built specifically for AU cap analogs, dsRNA reduction combined with lower reagent needs delivers higher quality, more cost-effective
More news about: Primrose Bio
Nov 09, 2025, 20:55 ET Kelun-Biotech Presented TROP2 ADC Sacituzumab Tirumotecan Results From Multiple Clinical Studies at the 2025 CCHIO Congress
antibodies, which is then endocytosed by tumor cells and releases the payload KL610023 intracellularly. KL610023, as a topoisomerase I inhibitor, induces DNA damage to tumor cells, which in turn leads to cell-cycle arrest and apoptosis. In addition, it also releases KL610023 in the tumor microenvironment.
More news about: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Nov 08, 2025, 08:30 ET AusperBio Announces Late-Breaking 48-Week Phase II Data of AHB-137 in Chronic Hepatitis B at AASLD 2025
responses 24 weeks after the end of treatment (Week 48), including complete response (HBsAg < 0.05 IU/mL and HBV DNA < LLOQ) and partial response (HBsAg < 10 IU/mL and HBV DNA < LLOQ). The 300 mg, 24-week regimen showed the highest response rates, with efficacy consistent across baseline
More news about: AusperBio Therapeutics Inc.
Nov 07, 2025, 19:29 ET U.S. FDA approves KYGEVVI™ (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d)
incorporate the pyrimidine nucleosides, deoxycytidine and deoxythymidine, into skeletal muscle mitochondrial DNA.1 This action restores mitochondrial DNA copy number in TK2d mutant mice.1 Important safety information for KYGEVVI1
More news about: UCB
Nov 07, 2025, 14:08 ET Bellagio and Major Food Group Unveil CARBONE RIVIERA, Ushering in a New Era of Fine Dining on the Las Vegas Strip
traditional dolci, such as Stracciatella Tiramisu and Sicilian Lemon Cheesecake. "CARBONE RIVIERA is a new chapter for CARBONE — same DNA, completely fresh expression — on a stage unlike anywhere else in the world," said Chef and Major Food Group Co-Founder Mario Carbone. "Here,
More news about: MGM Resorts International
Nov 07, 2025, 13:30 ET Landmark Data from Rutgers Cancer Institute and RWJBarnabas Health Show Long-term Complete Responses of T Cell Therapies for HPV-Related Cancers
cancers, the most common type of malignancy. A decade after treatment, patients exhibited no evidence of disease based on imaging and circulating tumor DNA analysis. Administered anti-tumor T cells underwent a temporary expansion phase that coincided with tumor shrinkage and apparent elimination. Tumor responses
More news about: Rutgers Cancer Institute and RWJBarnabas Health
Nov 07, 2025, 09:00 ET Scala Data Centers, Lightera, and Nokia conduct the first AccuCore HCF™ (Hollow Core Fiber) test in Latin America
infrastructure, pushing transmission speeds closer to the physical limits of light. "Innovation is in our DNA. Enabling the first hollow core fiber test in the Americas reinforces Scala's role as a cutting-edge platform for digital transformation and positions
More news about: Scala Data Centers
Nov 07, 2025, 08:58 ET Resonant Wins BioTech Breakthrough Awards' "DNA Sequencing Innovation Of The Year"
Resonant, a Renew Biotechnologies subsidiary developing novel diagnostic tools for neurodegenerative diseases, announces the receipt of "DNA Sequencing Innovation Of The Year" in the fifth annual BioTech Breakthrough Awards program. The awards are conducted by
More news about: Resonant
Nov 07, 2025, 08:52 ET Weltweit erste, auf APOC3 abzielende Gen-Editing-Therapie zur Behandlung von Hyperlipidämie
Einzelbasenkorrektur ohne DNA-Doppelstrangbrüche ermöglicht und damit eine überlegene Sicherheit gegenüber den auf CRISPR basierenden Gen-Editing-Therapien bietet. tBE vermeidet potenzielle Sicherheitsrisiken wie p53-Aktivierung, Chromosomenschäden, Off-Target-Effekte und Lebertoxizität, die durch DNA-Doppelstrangbrüche
More news about: CorrectSequence Therapeutics
Nov 06, 2025, 21:22 ET 世界初の APOC3 を標的とした高脂血症向け遺伝子編集治療薬
値を効果的に低下させます。疾患に遺伝子レベルでアプローチすることで、この治療は「一度の投与で、生涯にわたる効果」を実現することを目指しています。 CS-121 は次世代の tBE 技術を活用しており、DNA 二本鎖切断を伴わずに、単一塩基を正確に修復することが可能です。これにより、CRISPR に基づく遺伝子編集治療と比べて、より高い安全性を提供します。tBE は、DNA 二本鎖切断によって引き起こされる p53 活性化、染色体損傷、オフターゲット効果、肝毒性などの潜在的な安全性リスクを回避します。前臨床動物試験では、優れた安全性と長期的な有効性が示され、肝臓、肺、筋肉、脾臓、卵巣、心臓、腎臓など、さまざまな臓器においてオフターゲット編集は検出されませんでした。
More news about: CorrectSequence Therapeutics
Nov 06, 2025, 16:32 ET California Board of Education Approves Takeoff by IXL, California Edition
learning—from in-class student workbooks to independent practice pages. Differentiation is built into Takeoff's DNA Takeoff's digital platform powers deep, always-on personalization that goes far beyond what any traditional
More news about: IXL Learning
Nov 06, 2025, 16:05 ET Ginkgo Bioworks Reports Third Quarter 2025 Financial Results
BOSTON, Nov. 6, 2025 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced its results for the third quarter ended September 30, 2025. The update, including a webcast slide presentation with additional
More news about: Ginkgo Bioworks
Nov 06, 2025, 12:03 ET Perfect Moment x H&M brings style to the slopes with a new après-ski collaboration
''We've loved translating our distinct brand DNA into a perfect Apres-Ski capsule for H&M. Working with the teams in Stockholm has been a highlight moment to remember for sure. I can't wait to see
More news about: H&M
Nov 06, 2025, 10:29 ET New Study Links Gut Microbes to Common Heart Disease
The researchers compared fecal samples from 14 people with CAD to samples from 28 healthy people using metagenomic sequencing, which reveals all the DNA in a sample and can be used to reconstruct the genomes of individual microbes. Using this method of genomic reconstruction, Kim and her collaborators
More news about: American Society for Microbiology
Nov 06, 2025, 10:18 ET Wolverine Puts Boots on the Ground in "Landman" for a New Partnership with Paramount+'s Blockbuster Hit
the work, sacrifice, and legacy of the oil patch, we knew this was an opportunity for us to amplify stories that reflect our consumer and Wolverine's DNA. Both "Landman" and Wolverine celebrate the resilience, complexity, and humanity of modern tradespeople, as well as their families and communities."
More news about: Wolverine
Nov 06, 2025, 10:00 ET CODiE Awards Honor Nearpod + Freckle as Best Mathematics Instructional Solution
DnA for Best Content Authoring Development or Curation Solution,
More news about: Renaissance
Nov 06, 2025, 08:30 ET BJ's RESTAURANT REMIXES ITS ICONIC DEEP DISH PIZZA, TAKING THE BELOVED CLASSIC TO ALL NEW HEIGHTS
going back to the heart of its story, where it all began: pizza. Since 1978, BJ's signature take on Chicago-style deep dish has been at the heart of its DNA, often serving as a catalyst for bringing friends, family and communities together to share a good time over a great slice. Now, for the first time in
More news about: BJ’s Restaurants, Inc.
Nov 06, 2025, 08:00 ET Cure by Deerfield Middle East Health Accelerator Selects 15 Startups for Inaugural Cohort
bionic prosthetics for limb differences. DoriNano (USA): Programmable nanoparticle delivery (DNA-origami) powering oncology and partnered pipelines. EndoMD Health (USA): Digital-first endocrinology
More news about: Cure
Nov 06, 2025, 04:46 ET WuXi XDC Named the Winner of "Best CDMO" and "Best CRO" at 2025 World ADC Awards
efficiency to facilitate the smooth and rapid progression of projects. WuXi XDC has successfully supported global customers in advancing ADCs/XDCs from the DNA stage to IND applications within 15 months, and assisted customers in efficiently completing the transition from late-stage development to BLA within
More news about: WuXi XDC
Nov 06, 2025, 04:00 ET Nucleome Therapeutics founder Professor James Davies and Oxford University publish paper in prestigious journal Cell
changes in the intricate structure of DNA leads to conditions like heart disease, autoimmune disorders and cancer.' For more than two decades, scientists have known the full sequence of the human genome — the three billion "letters" of DNA that make up our genetic code. But exactly
More news about: Nucleome Therapeutics